These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8239299)

  • 21. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M1 muscarinic agonists as potential disease-modifying agents in Alzheimer's disease. Rationale and perspectives.
    Fisher A; Michaelson DM; Brandeis R; Haring R; Chapman S; Pittel Z
    Ann N Y Acad Sci; 2000; 920():315-20. PubMed ID: 11193170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
    Fisher A; Brandeis R; Bar-Ner RH; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z
    J Mol Neurosci; 2002; 19(1-2):145-53. PubMed ID: 12212772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective signaling via unique M1 muscarinic agonists.
    Fisher A; Heldman E; Gurwitz D; Haring R; Barak D; Meshulam H; Marciano D; Brandeis R; Pittel Z; Segal M
    Ann N Y Acad Sci; 1993 Sep; 695():300-3. PubMed ID: 8239299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in medicinal chemistry of novel selective muscarinic agonists.
    Fisher A; Karton Y; Heldman E; Gurwitz D; Haring R; Meshulam H; Brandeis R; Pittel Z; Segall Y; Marciano D
    Drug Des Discov; 1993; 9(3-4):221-35. PubMed ID: 8400004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.
    Fisher A; Heldman E; Gurwitz D; Haring R; Karton Y; Meshulam H; Pittel Z; Marciano D; Brandeis R; Sadot E; Barg Y; Pinkas-Kramarski R; Vogel Z; Ginzburg I; Treves TA; Verchovsky R; Klimowsky S; Korczyn AD
    Ann N Y Acad Sci; 1996 Jan; 777():189-96. PubMed ID: 8624083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.
    Fisher A; Pittel Z; Haring R; Bar-Ner N; Kliger-Spatz M; Natan N; Egozi I; Sonego H; Marcovitch I; Brandeis R
    J Mol Neurosci; 2003; 20(3):349-56. PubMed ID: 14501019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists.
    Fisher A
    Jpn J Pharmacol; 2000 Oct; 84(2):101-12. PubMed ID: 11128032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.
    Fisher A; Brandeis R; Haring R; Eshhar N; Heldman E; Karton Y; Eisenberg O; Meshulam H; Marciano D; Bar-Ner N; Pittel Z
    J Physiol Paris; 1998; 92(5-6):337-40. PubMed ID: 9789833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. M1 muscarinic agonists target major hallmarks of Alzheimer's disease--an update.
    Fisher A
    Curr Alzheimer Res; 2007 Dec; 4(5):577-80. PubMed ID: 18220527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of muscarinic agonists for successful therapy of Alzheimer's disease.
    Fisher A; Brandeis R; Haring R; Bar-Ner N; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z
    J Neural Transm Suppl; 2002; (62):189-202. PubMed ID: 12456063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptors.
    Fisher A
    Neurodegener Dis; 2008; 5(3-4):237-40. PubMed ID: 18322400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
    Verma S; Kumar A; Tripathi T; Kumar A
    J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.